Skip to content

Transfusion

Request correction

A monthly peer-reviewed medical journal focused on transfusion medicine and related blood and biotherapies research.

Last updated August 25, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Transfusion is a specialist scientific journal covering transfusion medicine, the clinical and laboratory science of blood transfusion, and related areas of blood and biotherapies research. The journal was established in 1960 and is published by Wiley on behalf of the Association for the Advancement of Blood and Biotherapies, the professional organization formerly associated with the journal's broader transfusion-medicine community. Its publishing model places it within the academic and professional journal sector rather than the consumer-brand market. The journal appears on a monthly publication schedule and uses peer review to assess submitted research and other scholarly contributions. Its subject area encompasses the collection, processing, testing, storage, and clinical use of blood and blood components, as well as issues involving transfusion safety, immunohematology, donor practice, blood banking, cellular therapies, and emerging biotherapies where relevant to the field. The available reference material identifies it as a medical journal, but does not provide a complete description of its article types, subscription model, geographic office structure, or commercial performance. Tibor J. Greenwalt served as the founding editor-in-chief when the journal was created in 1960. Richard Kaufman was identified as editor-in-chief as of 2021. Editorial leadership is a central part of the journal's identity because it guides the scope, peer-review standards, and scientific priorities of the publication. No additional current or former editors are established by the supplied materials. Transfusion is indexed or abstracted in a broad group of biomedical and scientific information services. These include Scopus, Index Medicus/MEDLINE/PubMed, EMBASE, CINAHL, BIOSIS Previews, CAB Abstracts, Current Contents/Clinical Medicine, Current Contents/Life Sciences, Biological Abstracts, and the Science Citation Index Expanded. Such coverage supports discoverability among clinicians, laboratory scientists, researchers, educators, and professionals working in blood services and transfusion practice. The journal's publisher relationship is with Wiley, while publication is conducted on behalf of the Association for the Advancement of Blood and Biotherapies. The supplied reference identifies a 2021 Journal Citation Reports impact factor of 3.337. This is a historical bibliometric figure for that reporting year, not a current financial or operating metric. No reliable information is supplied about circulation, revenue, subscription prices, article-processing charges, ownership structure, headquarters, or current impact factor. The journal remains an active scholarly title according to the reference material.

History

Transfusion was established in 1960 as a scholarly journal devoted to transfusion medicine. Its founding editor-in-chief was Tibor J. Greenwalt. From its inception, the publication occupied a specialist role at the intersection of clinical medicine, laboratory science, blood banking, and the professional practice of transfusion. Over time, the journal developed as a peer-reviewed medical periodical with a monthly publishing schedule. Its subject coverage is centered on research and professional knowledge relating to blood transfusion and associated biotherapies. The available reference material does not provide a detailed chronology of changes in format, title, publisher, editorial board, or article categories, so those developments cannot be reconstructed reliably here. The journal is published by Wiley on behalf of the Association for the Advancement of Blood and Biotherapies. This relationship connects the title with a professional medical organization while placing its production and distribution within Wiley's academic publishing operations. The journal's online presence is hosted through Wiley's journal platform. Transfusion has also been incorporated into major biomedical and multidisciplinary indexing systems. Its listed abstracting and indexing services include Scopus, MEDLINE/PubMed, EMBASE, CINAHL, BIOSIS Previews, CAB Abstracts, Current Contents databases, Biological Abstracts, and the Science Citation Index Expanded. Inclusion in these services has supported the journal's role as a discoverable source of research for clinicians, blood-service professionals, laboratory scientists, and academic researchers. Richard Kaufman was identified as editor-in-chief as of 2021. The journal's 2021 Journal Citation Reports impact factor was reported as 3.337. That metric describes citation performance for the specified reporting year and should not be treated as a permanent measure of the journal or as a financial result. The supplied sources do not establish the current editor-in-chief, current impact factor, headquarters, circulation, revenue, ownership, subscription terms, or detailed editorial history. The title is nevertheless described as an active monthly peer-reviewed journal.

  • 2021

    Richard Kaufman identified as editor-in-chief

    [1]

    Reference material identifies Richard Kaufman as the journal's editor-in-chief in 2021.

  • 2021

    Reported Journal Citation Reports impact factor

    [1]

    The journal's reported impact factor for 2021 was 3.337.

  • 1960

    Journal established

    [1]

    Transfusion was founded as a peer-reviewed medical journal focused on transfusion medicine, with Tibor J. Greenwalt as its founding editor-in-chief.

Products and positioning

A specialist peer-reviewed academic journal serving the international transfusion-medicine and blood-biotherapies research community.

  • Peer-reviewed medical journal · 1960

    Transfusion

    The core offering is a monthly peer-reviewed journal covering transfusion medicine and related blood and biotherapies research. It serves a professional and academic readership that includes clinicians, transfusion specialists, laboratory scientists, blood-service personnel, and researchers. Articles are distributed through Wiley's online journal platform and are discoverable through major biomedical and scientific indexing services.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/transfusion · Editorial policy · How profiles are compiled